The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors

Blood

Volumn 104, Issue 7, 2004, Pages 2010-2019

  Hildbrand, Patrick ^b   Cirulli, Vincenzo ^b   Prinsen, Robyn C ^b   Smith, Kent A ^b   Torbett, Bruce E ^b   Salomon, Daniel R ^b   Crisa, Laura ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; CD11B ANTIGEN; CD34 ANTIGEN;

ARTICLE; CARCINOGENESIS; CELL MATURATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; STEM CELL; UMBILICAL CORD BLOOD;

EID: 4644286776     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-12-4219     Document Type: Article

References (45)

1. Carmeliet P, Ferreira V, Breier G, et al. Abnormal vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435-439.
2. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in flk-1-deficient mice. Nature. 1995;376:62-66.
3. Dumont JD, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene. 1992;7:1471-1480.
4. Schnurch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development. 1993;119:957-968.
5. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptors tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376:70-74.
6. Korhonen J, Polvi A, Partanen J, Alitalo K. The mouse tie receptor tyrosine kinase gene: expression during embryonic angiogenesis. Oncogene. 1994;9:395-403.
7. Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the Tie-2 receptor, by secretion-trap expression cloning. Cell. 1996;87:1161-1169.
8. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science. 1997;277:55-60.
9. Dumont DJ, Gradwohl G, Fong GH, et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 1994;8:1897-1909.
10. Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1. Science. 1998;282:168-172.
11. Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science. 1999;286:2511-2514.
12. Hamaguchi I, Huang XL, Takakura N, et al. In vitro hematopoietic and endothelial cell development from cells expressing TEK receptor in murine aorta-gonad-mesonephros region. Blood. 1999;93:1549-1556.
13. Takakura N, Huang XL, Naruse T, et al. Critical role of the Tie-2 endothelial cell receptor in the development of definitive hematopoiesis? Immunity. 1998;9:6777-686.
14. Takakura N, Watanabe T, Suenobu S, et al: A role for hematopoietic stem cells in promoting angiogenesis. Cell. 2000;102:199-209.
15. Reynolds LP, Killilea SD, Redme DA. Angiogenesis in the female reproductive system. FASEB J. 1992;6:886-892.
16. Kirsner RS, Eaglstein WH. The wound healing process. Dermatol Clin. 1993;11:629-640.
17. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorogenesis. Cell. 1996;86:353-364.
18. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie-2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res. 1997;81:567-574.
19. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
20. Takahashi T, Kalka C, Masuda H, et al. Ischemia and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med. 1999;5:435-438.
21. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone-marrow-derived endothelial cells. Blood. 1998;2:362-367.
22. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest. 2000;105:71-77.
23. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for post-natal vasculogenesis in physiological and pathological neo-vascularization. Circ Res. 1999;85:221-228.
24. Crisa L, Cirulli V, Smith KA, Ellisman MH, Torbett BE, Salomon DR. Human cord blood progenitors sustain thymic T cell development and a novel form of angiogenesis. Blood. 1999;11:3928-3940.
25. Lyden D, Hattori K, Dias S, et al. Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001;7:1194-1201.
26. + cells identifies a population of functional endothelial precursors. Blood. 2000;95:952-958.
27. Hattori K, Dias S, Heissig B, et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med. 2001;193:1005-1014.
28. Kubota Y, Kleinman HK, Martin GR, Lawley T. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol. 1988;107:1589-1598.
29. Schechner JS, Nath AK, Zheng L, et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. Proc Natl Acad Sci U S A. 2000;97:9191-9196.
30. Lee K, Peters MC, Mooney DJ. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release. 2003;87:49-56.
31. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanatephenol-chlorophorm extraction. Analyt Biochem. 1987;162:156-159.
32. + lymphatic/vascular endothelial precursor cells. Blood. 2003;101:168-172.
33. Hildbrand P, Anderson KL, Crisa L, Salomon DR, Torbett BE. Hematopoietic progenitor-derived endothelial cells, but not human umbilical vein endothelial cells, express PU.1 [abstract]. Blood. 2001;98:3296a.
34. + cells. Eur J Hematol. 2003;70:143-150.
35. Kim I, Kim JH, Moon S, Kwak HJ, Kim N, Koh GY. Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Oncogene. 2000;19:4549-4552.
36. Huang X, Takakura N, Suda T. In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells. Biochem Biophys Res Commun. 1999;264:133-138.
37. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosyne kinase Tie-2. J. Biol Chem. 1998;273:18514-18521.
38. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 in trans to neighboring cells. 2002;17:537-547.
39. Kim I, Kim J, Ryu YS, Jung SH, Nah JJ, Koh GY. Characterization and expression of a novel alternatively spliced human angiopoietin-2. J. Biol Chem. 2000;275:18550-18556.
40. Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K, Wands JR. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest. 1999;103:341-345.
41. Brown LF, Dezube BJ, Tognazzi K, Dvorak HF, Yancopoulos GD. Expression of Tie-1, Tie-2 and angiopoietins 1,2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol. 2000;156:2179-2183.
42. - blood-derived human endothelia cell progenitors. Stem Cells. 2001;19:304-312.
43. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell. 1990;61:113-124.
44. McKercher SR, Torbett BE, Anderson KL, et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996;15:5647-5658.
45. + cells. Int J Hematol. 2003;77:245-252.